In simple words: A clot-busting drug is delivered through a vein to dissolve a blood clot in the brain, helping to restore blood flow and reduce the effects of a stroke.

This code describes a procedure where a thrombolytic drug is infused intravenously to dissolve a clot in a cerebral blood vessel. This aims to restore blood flow and prevent or minimize brain damage caused by a stroke.

Example 1: A 65-year-old patient presents to the emergency room with symptoms of acute ischemic stroke. After confirming the diagnosis and ruling out contraindications, the physician decides to administer intravenous thrombolysis using alteplase to dissolve the clot and restore blood flow to the affected brain area., A 70-year-old patient with a history of atrial fibrillation experiences sudden onset of right-sided weakness and speech difficulty. A CT scan confirms an ischemic stroke, and the patient is deemed eligible for intravenous thrombolysis within the appropriate time window. The physician initiates the infusion of a thrombolytic agent., A 55-year-old patient arrives at the hospital with symptoms suggestive of stroke. Imaging reveals a large vessel occlusion. The physician determines that intravenous thrombolysis is the most appropriate course of action and administers the thrombolytic drug to attempt to recanalize the occluded vessel.

Documentation should include the time of symptom onset, confirmation of ischemic stroke diagnosis (e.g., CT scan), neurological assessment, informed consent for thrombolysis, details of the thrombolytic agent used (dose, rate, and duration of infusion), monitoring parameters, and any adverse events or complications.